Full Breakdown
The Rise and Fall of Shandong Xinhua Pharmaceutical: A Viral Dance Challenge's Impact
2/22/2026, 10:20:42 PM
Viral Surge Amid Pandemic Easing
In late 2022, a viral dance challenge on the Chinese social media platform Douyin significantly boosted the shares of Shandong Xinhua Pharmaceutical, a leading manufacturer of ibuprofen. The challenge involved social media influencers mimicking poses from the packaging of ibuprofen, which resonated with users seeking lighthearted content during the Covid-19 pandemic. This surge in popularity led to a remarkable increase of over 200 percent in the company's stock within just two weeks. The timing coincided with China's shift away from its "zero-Covid" strategy, which included lifting lockdowns and reopening public venues.
Declining Profits and Market Challenges
Despite the initial surge, Shandong Xinhua Pharmaceutical is now facing significant financial challenges. The company's net profit for the first three quarters of 2025 has plummeted by 26 percent year-on-year, totaling 256.2 million yuan (approximately US$37 million). This decline continues a trend that began in 2024, when the company reported a 5.3 percent drop in full-year net profit compared to the previous year. The downturn has been attributed to oversupply in the market and weakening demand for fever and pain medications, prompting the company to implement price cuts on key products to maintain its market share.
Broader Industry Implications
Shandong Xinhua's struggles reflect broader challenges within the pharmaceutical industry in China. As demand for Covid-related medications decreases, many drug manufacturers are grappling with excess inventory and reduced sales. The initial spike in ibuprofen sales, driven by pandemic-related anxiety, has not sustained itself in the current market environment.
Official Statements & Responses
In its exchange filing, Shandong Xinhua Pharmaceutical acknowledged the impact of price reductions on its profitability, stating that these measures were necessary to defend its market position amid increasing competition and changing consumer behavior.
Criticism & Opposition
Critics of the pharmaceutical industry have pointed to the volatility of stock prices influenced by social media trends, arguing that such fluctuations can create unsustainable market conditions. The reliance on viral marketing strategies raises concerns about the long-term stability of companies like Shandong Xinhua, particularly in a post-pandemic landscape.
Conflicting Reports & Gaps
While Shandong Xinhua's financial reports indicate a significant profit decline, some analysts suggest that the overall market for pain relief medications may still hold potential for recovery as consumer habits stabilize. However, the exact future trajectory remains uncertain, with varying opinions on the sustainability of current market conditions.
Verbatim Quotes
“The company attributed the profit decline to price cuts on key products to defend its market share.” — Shandong Xinhua Pharmaceutical, Exchange Filing
The case of Shandong Xinhua Pharmaceutical illustrates the complex interplay between social media influence and market realities, highlighting both the opportunities and risks faced by companies in the rapidly evolving pharmaceutical landscape.
